238 related articles for article (PubMed ID: 37642211)
1. Refractory immune thrombocytopenia in adults: Towards a new definition.
Arnold DM; Clerici B; Ilicheva E; Ghanima W
Br J Haematol; 2023 Oct; 203(1):23-27. PubMed ID: 37642211
[TBL] [Abstract][Full Text] [Related]
2. A proposal for new definition (s) and management approach to paediatric refractory ITP: Reflections from the Intercontinental ITP Study Group.
Neunert C; Heitink-Polle KMJ; Lambert MP
Br J Haematol; 2023 Oct; 203(1):17-22. PubMed ID: 37641973
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
Kolonić SO; Patekar MB; Milunović V
Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
[TBL] [Abstract][Full Text] [Related]
4. Consensus Paper-ICIS Expert Meeting Basel 2009 treatment milestones in immune thrombocytopenia.
Tamary H; Roganovic J; Chitlur M; Nugent DJ
Ann Hematol; 2010 Jul; 89 Suppl 1(Suppl 1):5-10. PubMed ID: 20358200
[TBL] [Abstract][Full Text] [Related]
5. Management of patients with refractory immune thrombocytopenic purpura.
George JN
J Thromb Haemost; 2006 Aug; 4(8):1664-72. PubMed ID: 16879206
[TBL] [Abstract][Full Text] [Related]
6. Immune thrombocytopenia.
Bussel J; Cooper N; Boccia R; Zaja F; Newland A
Expert Rev Hematol; 2021 Nov; 14(11):1013-1025. PubMed ID: 34720027
[TBL] [Abstract][Full Text] [Related]
7. Chronic refractory immune thrombocytopenia in adolescents and young adults.
Schifferli A; Le Gavrian G; Aladjidi N; Moulis G; Godeau B; Kühne T
Br J Haematol; 2023 Oct; 203(1):36-42. PubMed ID: 37735549
[TBL] [Abstract][Full Text] [Related]
8. Current therapeutic strategies and perspectives in refractory ITP: What have we learned recently?
Lv Y; Shi H; Liu H; Zhou L
Front Immunol; 2022; 13():953716. PubMed ID: 36003388
[TBL] [Abstract][Full Text] [Related]
9. Current approaches for the diagnosis and management of immune thrombocytopenia.
Gafter-Gvili A
Eur J Intern Med; 2023 Feb; 108():18-24. PubMed ID: 36424271
[TBL] [Abstract][Full Text] [Related]
10. Immune Thrombocytopenia (ITP): Current Limitations in Patient Management.
Terrell DR; Neunert CE; Cooper N; Heitink-Pollé KM; Kruse C; Imbach P; Kühne T; Ghanima W
Medicina (Kaunas); 2020 Nov; 56(12):. PubMed ID: 33266286
[TBL] [Abstract][Full Text] [Related]
11. A multicenter retrospective analysis on therapeutic plasma exchange in immune thrombocytopenic purpura.
Basturk A; Sayin S; Erkurt MA; Sarici A; Ekinci O; Kum A; Berber I; Korkmaz S; Dogan A; Ulas T; Kuku I; Eser B; Altuntas F
Transfus Apher Sci; 2021 Oct; 60(5):103246. PubMed ID: 34419359
[TBL] [Abstract][Full Text] [Related]
12. Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives.
Vianelli N; Auteri G; Buccisano F; Carrai V; Baldacci E; Clissa C; Bartoletti D; Giuffrida G; Magro D; Rivolti E; Esposito D; Podda GM; Palandri F
Ann Hematol; 2022 May; 101(5):963-978. PubMed ID: 35201417
[TBL] [Abstract][Full Text] [Related]
13. Primary and secondary immune thrombocytopenia (ITP): Time for a rethink.
González-López TJ; Provan D; Bárez A; Bernardo-Gutiérrez A; Bernat S; Martínez-Carballeira D; Jarque-Ramos I; Soto I; Jiménez-Bárcenas R; Fernández-Fuertes F
Blood Rev; 2023 Sep; 61():101112. PubMed ID: 37414719
[TBL] [Abstract][Full Text] [Related]
14. Controversies in the treatment of immune thrombocytopenia.
Cuker A; Cines DB; Neunert CE
Curr Opin Hematol; 2016 Sep; 23(5):479-85. PubMed ID: 27380558
[TBL] [Abstract][Full Text] [Related]
15. [Current treatment of primary immune thrombocytopenia].
Lozano ML; Vicente V
Med Clin (Barc); 2014 May; 142(9):399-405. PubMed ID: 23809409
[TBL] [Abstract][Full Text] [Related]
16. Primary immune thrombocytopenia (ITP) treated with romiplostim in routine clinical practice: retrospective study from the United Kingdom ITP Registry.
Doobaree IU; Newland A; McDonald V; Nandigam R; Mensah L; Leroy S; Seesaghur A; Patel H; Wetten S; Provan D
Eur J Haematol; 2019 May; 102(5):416-423. PubMed ID: 30758874
[TBL] [Abstract][Full Text] [Related]
17. Immune thrombocytopenic purpura presenting in a patient after renal transplant for diabetic nephropathy.
Rashid RM; Nabi Z; Ansari AZ; Qaiser QA
BMC Nephrol; 2018 Mar; 19(1):69. PubMed ID: 29554892
[TBL] [Abstract][Full Text] [Related]
18. Treatment patterns and outcomes of second-line rituximab and thrombopoietin receptor agonists in adult immune thrombocytopenia: A Canadian retrospective cohort study.
Podstawka J; Wall E; Bolster L; Patterson JM; Goodyear MD; Rydz N; Sun HL
Thromb Res; 2022 Dec; 220():5-11. PubMed ID: 36257098
[TBL] [Abstract][Full Text] [Related]
19. Current options for the treatment of idiopathic thrombocytopenic purpura.
Arnold DM; Kelton JG
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S12-23. PubMed ID: 18096468
[TBL] [Abstract][Full Text] [Related]
20. Contemporary management of primary immune thrombocytopenia in adults.
Lakshmanan S; Cuker A
J Thromb Haemost; 2012 Oct; 10(10):1988-98. PubMed ID: 22863415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]